Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis
Authors:
- Ammar A. JavedAmmar A. Javed
- Marc G. BesselinkMBMarc G. Besselink
- for the PANC-PALS ConsortiumFCfor the PANC-PALS Consortium
Open Access
- 6 May 2024
- journal article
- review article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (7) , 4673-4687
Abstract
Background: Improved systemic therapy has made long term (≥ 5 years) overall survival (LTS) after resection of pancreatic ductal adenocarcinoma (PDAC) increasingly common. However, a systematic review on predictors of LTS following resection of PDAC is lacking. Methods: The PubMed, Embase, Scopus, and Cochrane CENTRAL databases were systematically searched from inception until March 2023. Studies reporting actual survival data (based on follow-up and not survival analysis estimates) on factors associated with LTS were included. Meta-analyses were conducted by using a random effects model, and study quality was gauged by using the Newcastle-Ottawa Scale (NOS). Results: Twenty-five studies with 27,091 patients (LTS: 2,132, non-LTS: 24,959) who underwent surgical resection for PDAC were meta-analyzed. The median proportion of LTS patients was 18.32% (IQR 12.97–21.18%) based on 20 studies. Predictors for LTS included sex, body mass index (BMI), preoperative levels of CA19-9, CEA, and albumin, neutrophil-lymphocyte ratio, tumor grade, AJCC stage, lymphovascular and perineural invasion, pathologic T-stage, nodal disease, metastatic disease, margin status, adjuvant therapy, vascular resection, operative time, operative blood loss, and perioperative blood transfusion. Most articles received a “good” NOS assessment, indicating an acceptable risk of bias. Conclusions: Our meta-analysis pools all true follow up data in the literature to quantify associations between prognostic factors and LTS after resection of PDAC. While there appears to be evidence of a complex interplay between risk, tumor biology, patient characteristics, and management related factors, no single parameter can predict LTS after the resection of PDAC.Keywords
This publication has 63 references indexed in Scilit:
- Hospital volume and outcomes of pancreatic cancer: a Finnish population-based nationwide studyHPB, 2022
- Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trialsEuropean Journal of Cancer, 2022
- Postoperative and long-term survival in relation to life-expectancy after pancreatic surgery in elderly patients (cohort study)Annals of Medicine & Surgery, 2021
- Long-term survival after pancreaticoduodenectomy in patients with ductal adenocarcinoma of the pancreatic headHepatobiliary & Pancreatic Diseases International, 2021
- Clinical predictive factors of long‐term survival after curative resection of pancreatic cancer: a retrospective studyCancer Medicine, 2017
- Characteristics of 10-Year Survivors of Pancreatic Ductal AdenocarcinomaJAMA Surgery, 2015
- Statistical methods for meta‐analyses including information from studies without any events—add nothing to nothing and succeed neverthelessStatistics in Medicine, 2014
- Does long-term survival in patients with pancreatic cancer really exist?-Results from the CONKO-001 studyJournal of Surgical Oncology, 2013
- Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- CA 19-9 Levels Predict Results of Staging Laparoscopy in Pancreatic CancerJournal of Gastrointestinal Surgery, 2005